The Risk of Acute Kidney Injury in Hepatitis B Virus-Related Acute on Chronic Liver Failure with Tenofovir Treatment

Table 3

Comparison changes in serum creatinine and cystatin C between the ETV and TDF group.

	ETV ()	TDF ()	(ETV vs. TDF)
sCr
Before treatment
After 2 weeks
Changes from baseline to 2 weeks			0.748
(baseline vs. 2 weeks)	0.080	0.565
After 4 weeks
Changes from baseline to 4 weeks			0.837
(baseline vs. 4 weeks)	0.072	0.285
Cystatin C
Before treatment
After 2 weeks
Changes from baseline to 2 weeks			0.810
(baseline vs. 2 weeks)	0.02	<0.001
After 4 weeks
Changes from baseline to 4 weeks			0.237
(baseline vs. 4 weeks)	0.044	0.011